Effective treatment of vasculitis: A Synthesis of Findings from 11 Studies

  1. Home
  2. Effective treatment of vasculitis
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of vasculitis: A Synthesis of Findings from 11 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of vasculitis: A Synthesis of Findings from 11 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Treatment for vasculitis has significantly advanced in recent years, particularly with the introduction of immunosuppressive therapies, leading to improved survival rates for patients. However, effective treatment options vary depending on the type and severity of vasculitis, and many questions remain unanswered regarding treatment. 2 , 5 , 7 , 8 . For example, further research is needed to understand optimal dosage and duration of therapy, the use of plasma exchange, and the role of new therapies.

In the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, immunosuppressive therapies have greatly improved patient survival, but they have also transformed ANCA-associated vasculitis (AAV) into chronic, relapsing disorders. 1 . Long-term treatment and disease-related morbidity are major concerns. Over the past decade, there has been a collaborative international effort to identify effective treatment options.

For immunoglobulin A vasculitis (IgAV), severe cases are typically treated with glucocorticoids and other conventional immunosuppressive drugs. 9 . The role of rituximab for resistant or refractory cases has been investigated in isolated case reports and small series.

Treatment Summary

Treatment for vasculitis involves the use of steroid and non-steroid medications, with plasma exchange used in certain situations. 2 , 5 , 7 , 8 . In ANCA-associated vasculitis, immunosuppressive agents like cyclophosphamide are effective, but they are associated with high rates of death and adverse events. 1 , 6 . Recently, safer treatment options like rituximab have been developed and are gaining attention. 6 , 11 .

Benefits and Risks

Benefit Summary

Immunosuppressive therapy has significantly improved survival rates for vasculitis patients. 3 . In particular, for ANCA-associated vasculitis, early diagnosis and appropriate treatment can reduce treatment-related toxicity and comorbidities. 3 . The development of new medications has made treatment safer, reducing the risk of side effects. 11 .

Risk Summary

Immunosuppressive therapy carries risks, such as infections. 11 . Immunosuppressive agents like cyclophosphamide can have long-term side effects, including infertility and malignancy. 4 .

Comparison of Studies

Commonalities

Most studies indicate that immunosuppressive therapy is effective in treating vasculitis. There is a general consensus that further research is needed to understand optimal dosage and duration of therapy, the use of plasma exchange, and the effectiveness of new therapies.

Differences

Each study examines different types and severities of vasculitis, treatment methods, and evaluation criteria. Therefore, direct comparison of study results is challenging. Furthermore, study sizes and patient characteristics vary, requiring caution in generalizing the findings.

Consistency and Contradictions of Results

Multiple studies demonstrate the effectiveness of immunosuppressive therapy in treating vasculitis. However, contradictions exist regarding specific treatment details and the efficacy of new therapies. These inconsistencies could be attributed to differences in study methods and patient characteristics.

Real-World Application Considerations

Treatment for vasculitis must be tailored to the individual patient's condition. Therefore, it is crucial to consult with a physician to select the appropriate treatment option. Regular checkups are necessary during treatment to ensure early detection of side effects.

Limitations of Current Research

Research on vasculitis treatment remains insufficient, particularly in regards to the effectiveness and safety of new therapies. More research is needed in this area.

Future Research Directions

Future research on vasculitis treatment should focus on developing new therapies, verifying the effectiveness and safety of existing therapies, and investigating the long-term effects of treatment.

Conclusion

Treatment for vasculitis has made significant strides in recent years, with the introduction of immunosuppressive therapies improving patient survival rates. However, many questions remain unanswered regarding treatment, and further research is needed to develop safer and more effective treatment options. Vasculitis treatment must be tailored to the individual patient's condition, and it is essential to consult with a physician to select the appropriate treatment option.

Treatment List

  • Steroids
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Plasma Exchange
  • Cyclophosphamide
  • Rituximab
  • Methotrexate
  • Azathioprine
Literature analysis of 11 papers
Positive Content
11
Neutral Content
0
Negative Content
0
Article Type
1
4
9
7
11
1.

Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.

Author: BoschXavier, GuilabertAntonio, EspinosaGerard, MirapeixEduard

Improved ANCA-associated vasculitis treatment
ANCA-associated vasculitis

While treatments for ANCA-associated vasculitis (AAV) have significantly improved survival, they have also made the disease chronic and prone to relapses. Managing the disease long-term and its complications are major challenges. Over the past decade, international collaboration has focused on finding effective treatments for AAV.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

2.

Interventions for renal vasculitis in adults.

Author: WaltersGiles, WillisNarelle S, CraigJonathan C

RPGN treatment

Treatment of renal vasculitis, presenting as rapidly progressive glomerulonephritis (RPGN), is discussed.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

3.

Mortality in systemic vasculitis: a systematic review.

Author: PhillipR, LuqmaniR

Earlier diagnosis
Improved survival rate
Comorbidities
Treatment-related toxicity

This review summarizes current survival rates in patients with small vessel, medium vessel, and large vessel vasculitis.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

4.

Pharmacotherapy of vasculitis.

Author: ChanMarian, LuqmaniRaashid

Vasculitis treatment
Infection
Infertility
Malignancy
Steroid side effects

Vasculitis is a group of diseases affecting blood vessels. While treatment approaches are based on the causes or how the disease works, this is not fully understood for many types. Treatment is often based on the symptoms and organs affected, and it is effective in improving survival for the most severe forms. Glucocorticoids are crucial for many types of vasculitis, and sometimes are the only treatment needed. However, other medications are required for other types, such as methotrexate for Takayasu's arteritis and small vessel vasculitis (excluding the kidneys), and cyclophosphamide for Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa, and Churg-Strauss syndrome. After the initial phase, lower doses of steroids are used with azathioprine or methotrexate. Biologics are used for treatment-resistant cases. Side effects can be significant, including infections and problems from steroids. Long-term risks of cyclophosphamide include infertility and cancer, but these are being reduced by using it for shorter periods and switching to safer medications.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

5.

Interventions for renal vasculitis in adults. A systematic review.

Author: WaltersGiles D, WillisNarelle S, CraigJonathan C

Treatment for renal vasculitis

This systematic review determined the benefits and harms of any intervention for the treatment of renal vasculitis in adults.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

6.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Author: JonesRachel B, TervaertJan Willem Cohen, HauserThomas, LuqmaniRaashid, MorganMatthew D, PehChen Au, SavageCaroline O, SegelmarkMårten, TesarVladimir, van PaassenPieter, WalshDorothy, WalshMichael, WestmanKerstin, JayneDavid R W,

Treatment for vasculitis
Adverse events

This article discusses the use of rituximab as a potential safer alternative to cyclophosphamide regimens for the treatment of refractory ANCA-associated vasculitis.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

7.

Interventions for renal vasculitis in adults.

Author: WaltersGiles, WillisNarelle S, CraigJonathan C

Treatment for renal vasculitis

This updated review examines the treatment of renal vasculitis, a condition characterized by rapidly progressive glomerulonephritis. The study discusses the use of steroids, non-steroid agents, plasma exchange, and the potential role of new therapies.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

8.

Interventions for renal vasculitis in adults.

Author: WaltersGiles D, WillisNarelle S, CooperTess E, CraigJonathan C

Improved renal vasculitis treatment

This updated review discussed the treatment of renal vasculitis, highlighting the challenges of determining optimal dose, duration, and the role of plasma exchange and new therapies.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

9.

Rituximab treatment for IgA vasculitis: A systematic review.

Author: Hernández-RodríguezJosé, CarbonellCristina, Mirón-CaneloJosé-A, Diez-RuizSandra, MarcosMiguel, ChamorroAntonio J

Improved IgAV treatment

This study explores the role of rituximab for resistant or refractory cases of immunoglobulin A vasculitis (IgAV), a systemic small vessel vasculitis.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

10.

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis.

Author: UghiN, PadoanR, CrottiC, SciasciaS, CarraraG, ZanettiA, RozzaD, MontiS, CamellinoD, MuratoreF, EmmiG, QuartuccioL, MorbelliS, El AoufyK, TonoloS, CaporaliR, De VitaS, SalvaraniC, CimminoM A

Diagnosis and treatment of LVV

This study updated the recommendations for the diagnosis and treatment of primary large-vessel vasculitis (LVV), incorporating new evidence from studies using conventional and biologic immunosuppressive drugs.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

11.

Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide.

Author: KrishnanAnoushka, WalshMichael, CollisterDavid

AAV treatment

AAV is an autoimmune disease affecting small blood vessels. Current treatments, including steroids, have improved outcomes but can cause serious side effects like infections. This review explores recent advancements in AAV treatment, highlighting newer therapies with potentially better safety profiles.

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.